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Epstein-Barr virus (EBV) is a highly prevalent herpesvirus associated with epithelial cancers, including nasopharyngeal carci-
noma (NPC). The EBV protein latent membrane protein 2 (LMP2) is expressed in NPC tumor tissue and has been shown to in-
duce transformation, inhibit differentiation, and promote migration of epithelial cells. In this study, the effect of LMP2A on mi-
gration of human epithelial cells was further analyzed. LMP2A expression induced migration in human foreskin keratinocytes
(HFK) and HaCaT keratinocytes measured by wound healing scratch assay and chemoattractant-induced Transwell migration
assay. The induction of migration by LMP2A required the ITAM signaling domain of LMP2A and activation of the Syk tyrosine
kinase. LMP2A-induced Transwell migration required the Akt signaling pathway, and activation of Akt by LMP2A required the
ITAM signaling domain of LMP2A. LMP2A also induced phosphorylation of the Akt target GSK3, a Wnt signaling mediator
that has been shown to regulate the activity of focal adhesion kinase (FAK), a tyrosine kinase activated by clustering and ligand
interaction of integrins. Inhibition of either FAK or its signaling mediator Src kinase inhibited LMP2A-induced migration. In-
terestingly, V-integrin was greatly increased in membrane-enriched fractions by LMP2A, and a neutralizing antibody to V-
integrin blocked migration, suggesting that the effects of LMP2A on membrane-localized V-integrin promoted migration. The
results of this study indicate that LMP2A expression in human epithelial cells induces V-integrin-dependent migration
through a mechanism requiring ITAM-mediated Syk and Akt activation and inducing membrane translocation or stabilization
of V-integrin and FAK activation. The specific effects of LMP2A on an integrin with a diverse repertoire of ligand specificities
could promote migration of different cell types and be initiated by multiple chemoattractants.
Epstein-Barr virus (EBV) is a widespread gammaherpesviruscharacterized by primary infection of the oral epithelium and
establishment of life-long latency. EBV is associated with the de-
velopment of several cancers, including Burkitt lymphoma,
Hodgkin lymphoma, and the epithelial cancer nasopharyngeal
carcinoma (NPC) (5, 6, 22–24, 36). During latent infection, mul-
tiple viral proteins are expressed, including the nuclear proteins
EBNA1, -2, -3A, -3B, and -3C and LP and the latent membrane
proteins LMP1, -2A, and -2B (25). LMP2 is consistently detected
in NPC tumor tissue at the RNA and protein levels and is thought
to contribute to the development of NPC through its effects on
epithelial cell growth (5, 6, 22, 24).
LMP2A likely contributes to a malignant phenotype in epithe-
lial cells through its effects on transformation, migration, and in-
hibition of differentiation (8, 11, 27). Malignant cells are highly
migratory and invasive, and LMP2A has also been shown to affect
migration (1, 16, 21). In one study using tonsillar epithelial cells,
LMP2 induced migration in a scratch assay and invasion through
Matrigel by upregulating 6-integrin (21). LMP2A has also been
shown to promote Transwell migration to collagen in HEK293
and HaCaT cells in a manner involving Syk activity and the
LMP2A ITAM domain (16). LMP1 also promotes migration and
features of epithelial-mesenchymal transition in epithelial cells,
and LMP1 can be coexpressed in NPC with LMP2 (29, 30). In the
context of an NPC tumor, LMP1 and LMP2 may have distinct
effects that cooperate to promote an invasive phenotype. Migra-
tion and invasion during tumor progression involves several fac-
tors, including integrin recycling, integrin activation, epithelial-
mesenchymal transition, and extracellular matrix (ECM)
remodeling (2). Integrins expressed on the surfaces of cells inter-
act with extracellular matrix (ECM) proteins and activate intra-
cellular signaling pathways that control cytoskeletal rearrange-
ment and motility (7).
LMP2A contains 12 hydrophobic transmembrane domains
with a long cytoplasmic N-terminal domain that contains several
signaling motifs. These include two PY domains that interact with
WW-containing ubiquitin ligases such as Itch (13, 28), an ITAM
domain that interacts with the tyrosine kinase Syk (9), and a YEEA
domain that in B cells interacts with the tyrosine kinase Lyn (10,
18). In B cells, LMP2A provides cell survival signals by mimicking
B cell receptor signaling and activating Syk through the ITAM
domain (9). The Akt pathway is also activated by LMP2A and
contributes to B cell survival (31). Akt is a serine/threonine pro-
tein kinase involved in controlling many cellular functions, in-
cluding cell survival and proliferation (32). LMP2A also activates
Akt signaling in epithelial cells and is required for LMP2A-in-
duced transformation (11, 27). Akt has been linked to migration
through effects on Ras-induced Fyn expression and focal adhesion
kinase (FAK) activation (35). FAK is activated by integrin-ECM
interaction and contributes to the regulation of adhesion and mi-
gration.
In this study, the effects of LMP2A on epithelial cell migration
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of immortalized, nontumorigenic HaCaT cells and HFK were an-
alyzed using both scratch assays and Transwell migration to FBS,
fibronectin, and collagen. The induction of migration required
the ITAM motif and activation of Syk, Akt, and FAK. Additionally,
LMP2A induced ITAM/Syk-dependent membrane translocation
and stabilization of V-integrin and neutralizing antibody to this
integrin blocked migration. It is likely that depending upon the
cell context, LMP2A may modulate other integrins. However, V-
integrin may be particularly significant, as it has a large repertoire
of ligands which would enable LMP2A to promote widespread
migration to different chemoattractants with effects that are po-
tentially distinct from those of different ligands that regulate mi-
gration. This study further defines the molecular events through
which LMP2A induces migration and reveals that LMP2A,
through the ITAM motif, activates Syk and Akt, which modulate
the membrane localization of integrins to activate FAK and induce
migration.
MATERIALS AND METHODS
Cell lines. Dedifferentiated HaCaT keratinocytes were maintained in cal-
cium-free Dulbecco’s modified Eagle medium (DMEM; Invitrogen,
Carlsbad, CA) supplemented with 10% chelated fetal bovine serum (FBS),
1% glutamine, and 1% penicillin-streptomycin in a humidified growth
chamber with 95% CO2. FBS was chelated with Chelex 100 resin (Bio-Rad
Laboratories, Hercules, CA) for 1 h on a rocker at 4°C and sterile filtered
to remove calcium. Human foreskin keratinocytes (HFK) were main-
tained in keratinocyte-SFM (Invitrogen, Carlsbad, CA) supplemented
with 1% penicillin-streptomycin. Cell lines were stably transduced with
retroviral vectors expressing pBabe vector control, LMP2A, or LMP2A
containing mutations for the signaling regions PY and ITAM as described
previously (8).
Wound healing scratch assays. HaCaT cells and HFK were plated on
6-well culture dishes and grown to confluence. Wells were scratched with
a sterile 1,000-l pipet tip, wound healing was visualized after 24 h, and
bright-field images were captured using a 5 objective from fixed and
crystal violet-stained cells using a Zeiss fluorescence microscope from the
Lineberger Comprehensive Cancer Center Tissue Culture Facility.
Transwell migration assays. Transwell migration chambers (Becton,
Dickinson Labware, Franklin Lakes, NJ) were coated overnight at 4°C
with the same chemoattractant that was used the following day to induce
migration. For cells induced to migrate to fibronectin, Transwell cham-
bers were coated overnight with fibronectin (10 g/ml) prepared in sterile
phosphate-buffered saline (PBS), and the following day, cells were al-
lowed to migrate to medium containing 1% FBS and fibronectin (20 g/
ml). For cells induced to migrate to collagen, Transwell chambers were
coated overnight with collagen (10 g/ml) prepared in sterile PBS, and the
following day, cells were allowed to migrate to medium containing 1%
FBS and collagen (20 g/ml). For cells induced to migrate to FBS, Trans-
well chambers were not precoated, and cells were allowed to migrate to
medium containing 10% FBS. For all Transwell experiments, cells were
suspended in medium containing 1% FBS, plated at 1.5  105 cells/cham-
ber, and allowed to migrate overnight at 37°C. After 24 h, the membranes
of the Transwell migration chambers were washed and then fixed with
ice-cold methanol, and cells were stained with the fluorescent DNA stain
4=,6-diamidino-2-phenylindole (DAPI) and visualized using a Zeiss up-
right fluorescence microscope from the Lineberger Comprehensive Can-
cer Center Tissue Culture Facility. For inhibitor experiments, cells were
treated with concentrations that were previously found to be inhibitory
and that were determined to be nontoxic in the treatments presented here.
The Syk inhibitor piceatannol (25 M), the Akt inhibitor triciribine (5
M), the GSK3 inhibitor LiCl (10 mM), the FAK inhibitors FAK14 (1
M) and PF573226 (500 nM), and the Src inhibitor PP2 (1 M) were
tested for effects on cell viability at the concentrations used in the migra-
tion studies by trypan blue exclusion 24 h after treatment at 37°C (see
Fig. 4C). For neutralizing-antibody experiments, cells were treated with
25 g/ml antibody (5-integrin [Millipore, Billerica, MA] and V-integ-
rin [BioLegend, San Diego, CA]) at 4°C for 1 h prior to initiation of
migration and for the duration of the assay. All Transwell migration data
are presented as average numbers of migrated cells/field, and each exper-
iment was performed in quadruplicate. Statistical data are presented from
Student’s t test analysis of data pairings.
Lysate preparation and Western blots. Whole-cell lysates were pre-
pared with radioimmunoprecipitation assay (RIPA) buffer for 30 min on
ice, followed by a 16,000  g spin for 10 min. Membrane-enriched lysates
were prepared by Dounce homogenization of cell pellets in ice-cold 1 mM
EDTA containing protease inhibitors. Lysates were centrifuged for 10 min
at 4°C and 300  g. Supernatants were collected and centrifuged at 4°C
and 20,000  g for 20 min. Membrane pellets were resuspended in 1 mM
EDTA. Proteins were resolved by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and were transferred to nitrocellulose.
Following a 1-h block of the membrane in 5% milk–Tris-buffered saline
(TBS)–Tween, membranes were incubated in primary antibody overnight
(1:1,000 anti-LMP2A [Abcam, Cambridge, MA], 1:2,000 HSC70 [Santa
Cruz Biotechnology, Santa Cruz, CA], 1:250 2-integrin [BD Biosci-
ences], 1:1,000 phospho-GSK3 [Ser9; Cell Signaling Technology, Dan-
vers, MA], 1:1,000 GSK3 [Upstate, now Millipore, Billerica, MA], 1:1,000
phospho-Akt [Ser473;] 1:1,000 Akt [Cell Signaling Technology, Danvers,
MA], 1:200 GRP78 [Santa Cruz Biotechnology, Santa Cruz, CA], 1:5,000
5-integrin [BD Biosciences], 1:250 V-integrin [BD Biosciences],
1:2,500 1-integrin [BD Biosciences], 1:250 6-integrin [GE Healthcare,
Little Chalfont, Buckinghamshire, United Kingdom], 1:200 phospho-
FAK [Santa Cruz Biotechnology, Santa Cruz, CA], and 1:1,000 FAK [Cell
Signaling Technology, Danvers, MA]). Secondary antibodies (Jackson
ImmunoResearch, West Grove, PA) were added for 1 h and incubated at
room temperature. Bands were visualized using Pierce SuperSignal West
Pico chemiluminescent substrate (Pierce, Rockford, IL), and densitome-
try was acquired using Image J (National Institutes of Health, Bethesda,
MD).
Immunofluorescence assays. HaCaT cells were seeded on 8-well glass
chamber slides and were allowed to attach overnight. Adherent cells were
then washed with PBS and were fixed for 15 min at 4°C with ice cold
acetone-methanol (1:1). Fixed cells were incubated for 20 min in blocking
buffer at room temperature (3% BSA in PBS). Primary antibodies were
diluted 1:50 in PBS and were incubated on blocked slides for 1 h at room
temperature in a humidified chamber. For secondary antibody-only con-
trols, slides were incubated in PBS. Following primary antibody incuba-
tion, slides were washed three times in PBS for 5 min and were incubated
with 1:100 fluorescein isothiocyanate (FITC)-conjugated secondary anti-
body for 1 h at room temperature in a humidified chamber. Following
secondary antibody incubation, slides were washed three times for 5 min
in PBS, incubated with 1:10,000 of DAPI to stain nuclei, and mounted
with antifade mounting medium. Images were acquired using a Zeiss 710
confocal laser scanning microscope located at the University of North
Carolina Microscopy Services Laboratory. All images shown were ac-
quired with a 63 oil objective.
RESULTS
The effects of LMP2A on epithelial cell migration were deter-
mined in two types of assays. The wound healing migration assay
measures cell movement that is similar to epithelial cell migration
in vivo in that when a confluent layer of cells is “scratched” or
“wounded,” cells move in sheets to close the wound while main-
taining cell-cell and cell-matrix contacts. In contrast, the Trans-
well migration assays quantitates migration of single cells to a
chemoattractant independent of cell-cell or cell-matrix attach-
ments.
LMP2A expression induces epithelial cell migration. LMP2A
has been previously shown to induce migration as assessed using a
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scratch assay (21) and by Transwell assay using fibronectin (1) and
collagen (16) as chemoattractants. The induction of both types of
migration and migration to two different chemoattractants sug-
gests that LMP2A may induce distinct types of migration through
a common mechanism. Previous studies using collagen as a che-
moattractant indicated a requirement for the Syk tyrosine kinase
signaling pathway (16) and induction of the laminin-binding
64 integrin (21). To further dissect the effects of LMP2A on
migration, the effects of LMP2A and activation of specific signal-
ing pathways were assessed in two nontumorigenic, immortalized
cell lines using both scratch assay migration and Transwell migra-
tion to different chemoattractants.
To evaluate the effects of LMP2A in a wound healing assay,
full-length LMP2A was stably expressed in the telomerase-im-
mortalized human foreskin keratinocyte (HFK) line, and full-
length LMP2A and mutants of the PY or ITAM motifs were stably
expressed in the spontaneously immortalized HaCaT cell line. Im-
munoblot analysis indicated approximately equivalent expression
of LMP2A and the mutants (Fig. 1A), and levels of LMP2A were
comparable to that expressed by the Burkitt lymphoma cell line
Jijoye. A comparison of wound healing after 24 h indicated that
LMP2A induced migration and closure of the wound in both cell
lines, in contrast to pBabe vector control cells (Fig. 1B and C). In
HaCaT cells, the wound closure and migration induced by
LMP2A expression was impaired in cells expressing the PY and
ITAM mutants, suggesting that both signaling domains were im-
portant for increased migration (Fig. 1C).
To compare LMP2A-induced wound healing with chemoat-
tractant-directed migration, epithelial cells were induced to mi-
grate for 24 h to FBS, collagen, and fibronectin. HFK pBabe con-
trol cells migrated efficiently to collagen and fibronectin, and
LMP2A expression did not enhance this migration (Fig. 1D). In
contrast, HFK migration induced by FBS was considerably lower
in pBabe control cells than that induced by fibronectin and colla-
gen but was significantly induced by LMP2A (Fig. 1D). In HaCaT
cells, LMP2A expression significantly induced migration to colla-
gen and fibronectin (Fig. 1E). Migration to FBS was also induced
but not as significantly as in HFK. Similar assessment of PY and
ITAM expressing cells revealed that the PY mutant did not impair
LMP2A-induced migration, while migration of cells containing
the ITAM mutant to all chemoattractants tested was reduced (Fig.
1E). To evaluate whether potential effects on cellular proliferation
were a factor contributing to LMP2A-induced migration, HaCaT
cells expressing the pBabe vector control, LMP2A, or the PY and
ITAM mutants were analyzed using an 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazo-
lium (MTS; inner salt) assay for 4 days. Cellular proliferation was
not affected by LMP2A or the LMP2A mutants (Fig. 1F), suggest-
ing that induction of migration by LMP2A in scratch and Trans-
well assays was a result of cell movement rather than proliferation.
LMP2A-induced migration requires the tyrosine kinase Syk.
The decreased wound healing and Transwell migration to FBS,
collagen, and fibronectin of HaCaT cells expressing the ITAM
mutant of LMP2A suggested that signaling mediated through the
ITAM domain was required to induce migration. The ITAM do-
main has been shown to interact with the tyrosine kinase Syk (9).
To evaluate the requirement for Syk activation in LMP2A-in-
duced migration, LMP2A expressing cells were induced to migrate
in the presence of the Syk inhibitor piceatannol. The Syk inhibitor
blocked LMP2A-induced wound healing in HFK (Fig. 2A) and
HaCaT cells (Fig. 2B), which were not affected by the dimethyl
sulfoxide (DMSO) vehicle control. Piceatannol also significantly
inhibited Transwell migration to FBS, fibronectin, and collagen in
pBabe control vector- and LMP2A-expressing HaCaT cells (Fig.
2C) and to FBS in pBabe- and LMP2A-expressing HFK (Fig. 2D),
indicating that all single-cell chemoattractant-directed migration
and wound healing migration induced by LMP2A in the scratch
assay required Syk signaling.
LMP2A-induced migration requires Akt signaling. The
LMP2A ITAM signaling domain has been shown to be required
for activation of Akt (31). Therefore, the contribution of Akt was
evaluated using the Akt inhibitor triciribine. In wound healing
assays in HFK, triciribine impaired LMP2A-induced migration,
indicating that Akt activation is important for LMP2A-mediated
migration (Fig. 3A). In HaCaT cells, triciribine partially blocked
LMP2A-induced migration measured by scratch assay (Fig. 3B).
Phosphorylation of the Akt target GSK3 by Akt inhibits GSK3
kinase activity, and it is thought that GSK3 induces an inhibitory
phosphorylation of FAK that would impair migration (4). To as-
sess the contribution of GSK3 in LMP2A-induced migration,
wound healing scratch assays were performed in the presence of
the GSK3 inhibitor lithium chloride (LiCl). Similarly to tricirib-
ine inhibition of Akt, LiCl unexpectedly inhibited LMP2A-in-
duced migration in HaCaT cells and HFK (Fig. 3A and B). It is
likely that GSK3 may impact migration in positive ways that are
required for migration.
To evaluate the contribution of Akt and GSK3 signaling in
chemoattractant-directed migration, epithelial cells were induced
to migrate to FBS, collagen, and fibronectin in the presence of
triciribine. Inhibition of Akt signaling decreased LMP2A-induced
migration to collagen in HaCaT cells; however, the decrease was
not statistically significant (Fig. 3C). However, triciribine treat-
ment completely blocked migration to fibronectin to levels below
pBabe (Fig. 3C), suggesting that Akt was required for fibronectin-
induced migration but contributed only to collagen-induced mi-
gration. Triciribine also impaired LMP2A-induced migration to
FBS in HFK (Fig. 3C). Similar to the effects on wound healing,
LiCl treatment mimicked Akt inhibition and blocked LMP2A in-
duced migration of HaCaT cells to fibronectin but not collagen
and decreased FBS stimulated migration of HFK (Fig. 3D).
LMP2A induces ITAM-dependent Akt signaling and activity
of focal adhesion kinase and Src. To evaluate the effects of
LMP2A and the PY and ITAM mutants on activation of Akt and
GSK3, levels of phosphorylated and total protein were deter-
mined by immunoblotting. LMP2A-expressing cells had elevated
levels of Akt phosphorylated at serine 473 and GSK3 phosphor-
ylated at serine 9, while total GSK3/ levels were not affected and
Akt levels were elevated by LMP2A (Fig. 4A). The levels of phos-
phorylated Akt were decreased in the ITAM-expressing cells and
less so in the PY cells. Phosphorylated GSK3 levels were de-
creased in both the PY and ITAM-expressing cells (Fig. 4A). These
data confirm previous studies indicating that the ITAM motif is
required for LMP2A activation of Akt.
To assess the effects of the inhibitors used in the migration
studies on their respective signaling targets, HaCaT cells express-
ing LMP2A were treated with piceatannol, triciribine, lithium
chloride, and the Src family kinase inhibitor, PP2, at the same
concentration that was tested for migration effects, and the effects
on the protein levels and phosphorylation of Akt, GSK3, and Src
were determined by immunoblotting. To determine the amount
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of increase in phosphorylation and activation of the specific pro-
tein, the amount of phosphoprotein detected was determined rel-
ative to the total protein level and expressed relative to that in the
LMP2A DMSO vehicle controls. The data from three experiments
are presented graphically. Piceatannol, which clearly blocked mi-
gration, did not decrease the levels of phosphorylated Akt,
GSK3, or Src (Fig. 4B) induced by LMP2A. This lack of effect on
the LMP2-induced phosphorylation of other targets supports the
specificity of piceatannol treatment. These findings also reveal
that although the ITAM is required for Akt activation, Syk activity
is not required for activation of Akt. Triciribine treatment signif-
icantly decreased p-Akt and also reduced phosphorylation levels
of the Akt target p-GSK3 (Fig. 4B) but did not decrease levels of
p-Src. Lithium chloride treatment completely blocked phosphor-
ylation of Akt and significantly decreased phosphorylated GSK3
but did not decrease phosphorylated Src (Fig. 4B). The block of
FIG 1 LMP2A induces ITAM-dependent migration. (A) HaCaT cells were transduced to stably express the pBabe vector, wild-type LMP2A, and PY and ITAM
mutants of LMP2A. HFK were transduced to stably express the pBabe vector and wild-type LMP2A. LMP2A levels were compared to the level in the Burkitt
lymphoma cell line Jijoye. LMP2A expression was determined by Western blotting using HSC70 expression to demonstrate equal loading. (B) Wound healing
of HFK expressing pBabe and LMP2A was determined by scratch assay. Images were acquired at a 5 magnification from crystal violet-stained cells 24 h after
scratching (n  5). (C) Wound healing of HaCaT cells expressing pBabe, LMP2A, LMP2A PY, and LMP2A ITAM was determined by scratch assay (n  6). (D)
Transwell migration of HFK expressing pBabe and LMP2A was determined using collagen (CL), fibronectin (FN), and FBS as chemoattractants as described in
Materials and Methods. Data are averages (n  2). a, P  0.001 versus pBabe. (E) Transwell migration of HaCaT cells expressing pBabe, LMP2A, LMP2A PY, and
LMP2A ITAM was determined using collagen (CL), fibronectin (FN), and FBS as chemoattractants as described in Materials and Methods. Data are averages (n 
2). b, P  0.0051 versus pBabe; c, P  0.0071 versus pBabe; d, P  0.0054 versus pBabe. (F) Proliferation of HaCaT cells expressing pBabe, LMP2A, LMP2A PY,
and LMP2A ITAM was measured by MTS assay.
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activation of Akt in the presence of LiCl supports the biologic
findings that showed inhibition of migration resulting from inhi-
bition of Akt by triciribine or treatment with LiCl. The Src inhib-
itor PP2 significantly decreased phosphorylation of Src but also
decreased the relative phosphorylation levels of Akt and GSK3
(Fig. 4B), suggesting that Src may contribute to effects on Akt and
GSK3. It is thought that in B cells, the Src family kinase Lyn
activates the ITAM domain to induce recruitment and activation
of Syk to LMP2A. The decrease in Akt activation by the Src inhib-
itor suggests that Src family kinase activity and ITAM activation
may both be required for Akt activation, although activation of Src
and Akt is independent of Syk. These data indicate that the treat-
ment with the kinase inhibitors blocked phosphorylation of ex-
pected targets but did not inhibit LMP2-mediated effects on other
targets.
To determine effects of the inhibitors on cell viability, cells
were treated for 24 h at the concentrations that were evaluated in
biologic and molecular assays. At the effective concentration,
none of the drugs used in this study had any effect on viability.
These findings confirm that the effects on migration and phos-
phorylated protein levels were due to effects of the drugs on their
targets and not cellular toxicity (Fig. 4C).
LMP2A-induced migration involves FAK and Src signaling.
GSK3 signaling has been shown to control activation of focal
adhesion kinase (FAK) (4). FAK is activated by integrin clustering
upon interaction with extracellular matrix proteins, and active
FAK recruits signaling mediators, including Src, to control cellu-
lar migration. To determine if FAK and Src signaling contributed
to LMP2A-induced migration, wound healing and Transwell mi-
gration assays were conducted in the presence of two FAK inhib-
itors (FAK14 and PF573226) and a Src inhibitor (PP2). Inhibition
of FAK blocked wound healing migration in HFK (Fig. 5A) and
HaCaT cells (Fig. 5B). Both FAK inhibitors also significantly im-
paired LMP2A-induced migration to fibronectin in HaCaT cells
and to FBS in HFK (Fig. 5C) but did not affect LMP2A-induced
migration to collagen (Fig. 5C), suggesting that only FBS and fi-
bronectin-directed migration required FAK signaling. Inhibition
of Src signaling with PP2 inhibited LMP2A-induced wound heal-
ing in both HFK and HaCaT cells (Fig. 5D and E). Src inhibition
blocked LMP2A-induced migration to both fibronectin and col-
lagen in HaCaT cells but did not impair migration to FBS in HFK
(Fig. 5F). This difference suggests that distinct signaling mediators
are activated by FAK during FBS-induced migration in HFK.
These findings indicate a general requirement for FAK and dis-
tinct requirements for Src activation in wound healing and Trans-
well migration in epithelial cells.
To determine whether LMP2A affects the phosphorylation sta-
tus of FAK, Western blots were used to measure FAK phosphory-
lated at the serine 722 residue. It has been shown that active
GSK3 can phosphorylate FAK on serine 722 and inhibit FAK
signaling (4). It is thought that the activation of Akt by LMP2
results in inhibition of GSK3 as detected by phosphorylation on
the Akt target serine 9 (Fig. 4C). To determine if these effects of
LMP2 on GSK3 affected FAK inhibition, the phosphorylation of
FAK at the putative GSK3 target serine 722 was evaluated. In
HFK and HaCaT cells, the inhibitory phosphorylation of FAK at
serine 722 was reduced in the presence of LMP2A (Fig. 5G). The
effect of LMP2A on decreased inhibitory FAK phosphorylation
was not affected by mutation of the PY or ITAM motif (Fig. 5G).
The lack of effect of these mutations, which both impair activation
of Akt and inhibition of GSK3, suggests that the absence of the
inhibitory phosphorylation on FAK is not specifically mediated by
LMP2A and likely reflects the general activation of FAK.
LMP2A induces Syk/ITAM-dependent translocation of V-
integrin- and V-integrin-dependent migration. Integrin clus-
tering and interaction with extracellular matrix ligands induces
FIG 2 LMP2A induces Syk-dependent migration. Wound healing of HFK (A)
and HaCaT cells (B) was determined by scratch assay in the presence of DMSO
vehicle control or the Syk inhibitor piceatannol (25 M; n  3 [HFK]; n  4
[HaCaT]). (C) Transwell migration of HaCaT cells to collagen, fibronectin,
and FBS was determined in the presence of piceatannol and DMSO vehicle
control as described in Materials and Methods. Data are averages (n  2). a,
P  0.01034 versus pBabe DMSO; b, P  6.7  105 versus pBabe DMSO; c,
P  0.00265 versus pBabe DMSO. (D) HFK Transwell migration to FBS was
determined in the presence of piceatannol and DMSO vehicle control as de-
scribed in Materials and Methods. Data are averages (n  2). d, P  0.03026
versus pBabe DMSO.
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FAK activation and autophosphorylation. As FAK signaling was
required for LMP2A-induced wound healing and Transwell mi-
gration to fibronectin and FBS, the effects of LMP2A on integrin
expression were assessed. Immunoblot analysis of whole-cell ly-
sates and membrane-enriched lysates detected V-, 2-, 5-, 6-,
and 1-integrins in whole-cell lysates from HaCaT cells (Fig. 6A)
and HFK (Fig. 6B). Expression of 3-, L-, and 3-integrins were
not detected in HaCaT cells or HFK (data not shown). Expression
of V-, 2-, and 1-integrins was essentially unchanged in pBabe,
LMP2A, and the PY and ITAM mutants in HaCaT cells. Expres-
sion of 6-integrin was modestly upregulated by LMP2A (Fig.
6A). 5-Integrin was induced by LMP2A in whole-cell lysates, and
this induction required the PY and ITAM signaling domain (Fig.
6A). In HFK, LMP2A did not affect expression of any of the tested
integrins (Fig. 6B). Integrin signaling is induced by ligand binding
and modulated by membrane localization; therefore, membrane-
enriched fractions were evaluated for integrin expression. The 2-
integrin was detected in the membrane fraction of all cell lines,
with a small increase being detected in LMP2A-expressing HaCaT
cells (Fig. 6C). In contrast, the V-integrin was detected only in
the membrane fractions from LMP2A-expressing HaCaT cells,
not the pBabe control cells (Fig. 6C). This induction of V-integ-
rin required the ITAM motif of LMP2A but not the PY motif (Fig.
6C). The 5-integrin was not detected in the membrane fraction
(data not shown). Expression of LMP2A and the mutants was
readily detected in the membrane enriched fractions. Similarly in
HFK, expression of LMP2 induced the membrane translocation of
V-integrin. Analysis of three independent cell lines indicated
that the translocation of V-integrin was directly proportional to
LMP2A expression (Fig. 6D). Thus, LMP2A induced membrane
translocation of V-integrin in both HaCaT cells and HFK.
As the ITAM motif was required for membrane translocation
of V-integrin, the contribution of Syk was determined using
piceatannol. HaCaT cells were treated with the Syk inhibitor
FIG 3 LMP2A-induced migration involves Akt and GSK3 signaling. Wound healing of HFK (A) and HaCaT cells (B) expressing pBabe vector and wild-type
LMP2A in the presence of the Akt inhibitor triciribine (TCN; 5 M), the GSK3 inhibitor LiCl (10 mM), or DMSO vehicle control was determined by scratch
assay. Images represent three individual experiments for LiCl and four individual experiments for triciribine. (C) Transwell migration of HaCaT cells to collagen
(CL) and fibronectin (FN) and migration of HFK to FBS was determined in the presence of triciribine (TCN) and DMSO vehicle control as described in Materials and
Methods. a, P  0.00174 versus pBabe DMSO; b, P  0.09066 versus LMP2A DMSO; c, P  0.01624 versus pBabe DMSO; d, P  1.6  107 versus LMP2A DMSO;
e, P  0.01248 versus pBabe DMSO; f, P  0.00487 versus LMP2A DMSO. (D) Transwell migration of HaCaT cells to collagen (CL) and fibronectin (FN) and migration
of HFK to FBS was determined in the presence of LiCl and DMSO vehicle control as described in Materials and Methods. g, P  0.00528 versus pBabe DMSO; h, P 
0.26713 versus LMP2A DMSO; i, P  0.00571 versus pBabe DMSO; j, P  0.03775 versus LMP2A DMSO; k, P  0.00025 versus pBabe DMSO; l, P  3.4  106 versus
LMP2A DMSO. All Transwell migration data are averages (n  2; experiments were performed in quadruplicate).
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piceatannol and DMSO vehicle control for 24 h prior to prepara-
tion of membrane-enriched lysates. V- and 2-integrin expres-
sion was increased in LMP2A-expressing cells, and the LMP2A-
induced membrane translocation of V-integrin was impaired by
piceatannol (Fig. 6E), indicating that the LMP2A induction of
V-integrin in the membrane fraction required the ITAM motif
and Syk activation. Syk inhibition did not affect the steady-state
level of 2-integrin in the membrane-enriched lysates.
As LMP2A activation of Akt also requires the ITAM motif, the
contribution of Akt and Src activation to V-integrin membrane
enrichment was evaluated. Treatment of HaCaT cells with
triciribine decreased V-integrin in the membrane but not below
levels detected in the vector control cells (Fig. 6F). Inhibition of
Src with PP2 did not affect the translocation of V-integrin. These
findings suggest that Akt contributes to V-integrin membrane
enrichment and that activation of Src kinase family members ap-
parently is not required for the effects of LMP2A on integrin
membrane translocation.
To evaluate the contribution of V-integrin in chemoattrac-
tant-dependent migration induced by LMP2A, Transwell migra-
tion assays were performed in the presence of neutralizing anti-
body to V-integrin, 5-integrin, and an IgG isotype control.
Neutralizing antibody to V-integrin but not 5-integrin signifi-
cantly impaired LMP2A-induced migration to FBS in HFK (Fig.
6G). In HaCaT cells, antibody to either V-integrin or 5-integ-
rin inhibited migration to both collagen and fibronectin (Fig. 6H
and I).
To further assess the effects of LMP2A-induced membrane lo-
FIG 4 LMP2A induces Akt signaling and activation of focal adhesion kinase. (A) Protein expression of Wnt signaling mediators was measured by Western
blotting in cytoplasmic lysates from HaCaT cells expressing pBabe, wild-type LMP2A, and the LMP2A PY and ITAM mutants. Equal loading was determined by
expression of the endoplasmic reticulum protein GRP78. Expression of phosphoproteins was normalized to total levels and is expressed relative to LMP2A
DMSO vehicle controls; averages from three experiments are presented. (B) Protein levels of Akt, GSK3, and Src were determined by Western blotting using
antibodies to total protein or phosphorylated residues. Whole-cell lysates from pBabe and wild-type LMP2A expressing HaCaT cells were prepared from cells
following treatment with DMSO vehicle control, the Syk inhibitor piceatannol (25 M), the Akt inhibitor triciribine (TCN; 5 M), the GSK3 inhibitor LiCl (10
mM), and the Src inhibitor PP2 (500 nM). Expression of phosphoprotein was normalized to total levels and expressed relative to values for LMP2A DMSO vehicle
controls, and quantitation of two experiments is presented. a, P  4.42  109 versus LMP2A DMSO; b, P  0.00027 versus LMP2A DMSO; c, P  0.0272 versus
LMP2A DMSO; d, P  0.0267 versus LMP2A DMSO; e, P  0.011 versus LMP2A DMSO; f, P  0.00587 versus LMP2A DMSO. (C) HaCaT cells expressing
pBabe and wild-type LMP2A were treated overnight with DMSO vehicle control, triciribine (5 M), piceatannol (25 M), FAK14 (1 M), LiCl (10 mM), and
PP2 (500 nM). Cells were collected 24 h after treatment and cell viability was determined by trypan blue exclusion.
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calization of V-integrin in epithelial cells, expression of V- and
2-integrins was determined using immunofluorescent staining
in HaCaT cells expressing pBabe vector control and wild-type
LMP2A. Expression of 2-integrin was uniform throughout the
cytoplasm, and its distribution and localization was similar in
pBabe and LMP2A cells (Fig. 7A). The intensity of staining was
increased in some LMP2A-expressing cells compared to that in
pBabe-expressing cells. In contrast, staining of V-integrin re-
FIG 5 LMP2A induces FAK and Src-dependent migration. Wound healing in HFK (A) and HaCaT cells (B) expressing pBabe vector and wild-type LMP2A in
the presence of the FAK inhibitors FAK14 (1 M) and PF573228 (500 nM) and DMSO vehicle controls was determined by scratch assay. Images are represen-
tative of three individual experiments for both cell lines with each drug. (C) Transwell migration of HaCaT cells to collagen (CL) and fibronectin (FN) and
migration of HFK to FBS were determined in the presence of FAK14, PF573228, and DMSO vehicle control as described in Materials and Methods and are
expressed as averages (n  2). a, P  1.54  105 versus pBabe DMSO; b, P  0.00021 versus LMP2A DMSO; c, P  0.00808 versus LMP2A DMSO; d, P 
0.00412 versus pBabe DMSO; e, P  0.03214 versus LMP2A DMSO; f, P  0.0015 versus LMP2A DMSO; g, P  0.00011 versus pBabe DMSO; h, P  0.00704
versus LMP2A DMSO; i, P  0.0221 versus LMP2A DMSO. Wound healing in HFK (D) and HaCaT cells (E) expressing pBabe vector and wild-type LMP2A in
the presence of the Src inhibitor PP2 (500 nM) and DMSO vehicle control was determined by scratch assay. (F) Transwell migration of HaCaT cells to collagen
(CL) and fibronectin (FN) and migration of HFK to FBS was determined in the presence of PP2 and DMSO vehicle control as described in Materials and Methods
and is expressed as averages (n  2). j, P  0.00174 versus pBabe DMSO; k, P  0.03209 versus LMP2A DMSO; l, P  0.01624 versus pBabe DMSO; m, P 
0.00021 versus LMP2A DMSO; n, P  0.01583 versus pBabe DMSO; o, P  0.95127 versus LMP2A DMSO. (G) Protein levels of phospho-FAK (serine 722), total
FAK, and the loading control HSC70 were determined by Western blotting of whole-cell lysates prepared from HFK expressing pBabe vector and wild-type
LMP2A and from HaCaT cells expressing pBabe vector, wild-type LMP2A, and the LMP2A PY and ITAM mutants. phospho-FAK expression was normalized to
total FAK, expressed relative to pBabe, and averages from two experiments are presented.
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FIG 6 LMP2A induces V-integrin membrane expression and V-integrin-dependent migration. Integrin expression in HaCaT cells (A) and HFK (B) was
determined by Western blotting from whole-cell lysates. (C) LMP2A, 2-integrin, and V-integrin expression was measured in HaCaT cell membrane-enriched
lysates by Western blotting. (D) V-integrin and LMP2A expression was measured by Western blotting in membrane lysate preparations from three independent
HFK expressing different levels of LMP2A. (E) Protein expression of V-integrin, 2-integrin, and LMP2A was measured by Western blotting in HaCaT pBabe
(pB) and LMP2A (L2A) membrane-enriched lysates following 24 h treatment with DMSO vehicle control (pB-D, L2A-D) or the Syk inhibitor piceatannol (pB-P,
L2A-P). (F) Protein expression of V-integrin and LMP2A in HaCaT cells expressing pBabe (pB) and wild-type LMP2A (L2A) was measured by Western blotting
following 24 h treatment with DMSO vehicle control, the Akt inhibitor triciribine (TCN; 5 M), or the Src inhibitor PP2 (500 nM). (G) HFK were treated for 1
h with IgG control antibody, V-integrin, or 5-integrin neutralizing antibody prior to initiation of Transwell migration to FBS for 24 h. HaCaT cells were
treated for 1 h with IgG control antibody, V-integrin, or 5-integrin neutralizing antibody prior to initiation of Transwell migration to collagen (H) and
fibronectin (I) as described in Materials and Methods. Data are expressed as averages (n  2; experiments were performed in quadruplicate). a, P  0.00012
versus pBabe IgG; b, P  0.012 versus LMP2A IgG; c, P  0.304 versus LMP2A IgG; d, P  9.4  106 versus pBabe IgG; e, P  0.02566 versus LMP2A IgG; f,
P  7.7  105 versus LMP2A IgG; g, P  0.17584 versus pBabe IgG; h, P  0.05476 versus LMP2A IgG; i, P  0.19075 versus LMP2A IgG.
Fotheringham et al.
10316 jvi.asm.org Journal of Virology
vealed distinct patterns of distribution and cellular localization in
pBabe-expressing cells compared with those expressing wild-type
LMP2A. LMP2A cells had increased cytoplasmic staining of V-
integrin extending to the cell membrane and throughout the cel-
lular extensions, whereas pBabe-expressing cells had striking pe-
rinuclear staining and punctate staining within the nucleus and
very little V-integrin localized throughout the cytoplasm or in
cell extensions (Fig. 7B and C). The different localization of V-
integrin detected by immunofluorescence in pBabe compared
with LMP2A cells supports the increased immunoblot detection
in membrane-enriched fractions. These findings indicate that
LMP2A induces a cellular translocation of V-integrin to the
membrane and throughout cellular extensions that facilitates mi-
gration.
LMP2A-induces distinct signaling pathways to induce mem-
brane translocation of V-integrin and promote migration. The
data presented in this study show that LMP2A induces two signal-
ing pathways that require the ITAM domain (Fig. 8). Syk and Akt
are activated independently, although both converge to promote
the membrane translocation of V-integrin. FAK and Src are sub-
sequently activated downstream of integrin clustering in a manner
that has been well documented to promote migration. The activa-
tion of Akt may also be enhanced by the effects of Src family
kinases on activation of the ITAM signaling domain. GSK3 has
been shown to phosphorylate FAK on a residue that inhibits its
activity. By inhibiting GSK3, Akt may contribute to activation of
FAK by blocking the inhibitory phosphorylation of FAK as a
mechanism to control migration in addition to promoting mem-
brane localization of V-integrin.
DISCUSSION
This study investigated the effects of the EBV protein LMP2A on
the migratory properties of human epithelial cells and the cellular
pathways that are affected by LMP2A to control migration.
LMP2A induced migration in the HaCaT keratinocyte cell line
and the human foreskin keratinocyte (HFK) cell line, as deter-
FIG 7 LMP2A induces translocation of V-integrin. Expression and cellular localization of 2-integrin (A) and V-integrin (B) was determined by immuno-
fluorescence assay in HaCaT cells expressing pBabe and LMP2A. (C) Higher-magnification images of pBabe and LMP2A-expressing cells stained for V-integrin.
Mouse primary antibodies were used to detect expression to V-integrin and 2-integrin, were visualized with an anti-mouse secondary antibody conjugated to
FITC, and are shown in green. Nuclei were stained with DAPI and are shown in blue. Differential interference contrast (DIC) and overlay images are also shown.
All images were acquired using a Zeiss 710 confocal microscope from the UNC Microscopy Services Laboratory. Brightness and contrast were adjusted to all parts
of the images using Adobe Photoshop software.
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mined by a wound healing scratch assay and by a chemoattrac-
tant-directed Transwell assay using three different chemoattrac-
tants. The ability of LMP2A to induce migration in the scratch
assay, which measures migration of cells that maintain cell-cell
and cell-matrix contacts, and in the Transwell assay, which mea-
sures single-cell chemoattractant-directed migration, indicates
that LMP2A broadly regulates cellular migration through effects
on common pathways. All migration tested required the ITAM
signaling domain of LMP2A and was inhibited by the Syk inhibi-
tor piceatannol. The pBabe controls were also inhibited by picea-
tannol, indicating that activation of Syk is required for epithelial
cell migration. Scratch assay migration induced by LMP2A was
blocked by inhibitors of Akt, GSK3, FAK, and Src in both cell
lines. These findings indicate that the activation of ITAM/Syk,
Akt, and FAK/Src by LMP2A is generally required for induced
migration. The inhibition of migration by LiCl treatment was un-
expected, as GSK3 is thought to be inhibited by Akt and to in-
duce inhibitory phosphorylation of FAK. However, LiCl has also
been shown to inhibit migration in studies with HeLa and CHO
cells that have suggested that GSK3 promotes migration, and it
has been suggested that one mechanism may be inhibition of Akt
transcription (14, 20). However, as shown here, LiCl did not re-
duce total Akt levels but eliminated phospho-Akt. Overall, these
findings suggest that the inhibitory effects of GSK3 on migration
reflect the block in phosphorylation of Akt.
One difference in the LMP2A-induced signaling pathways in-
volved in epithelial migration was the requirement of the PY do-
main for wound healing but not for Transwell migration. The PY
domains of LMP2A interact with WW domain-containing pro-
teins, including the Nedd4-like ubiquitin ligase Itch (13). Re-
cently, Itch was shown to ubiquitinate and regulate the expression
of angiomotin (AMOT). AMOT family members are involved in
angiogenesis, integrity of tight junctions, formation of lamellipo-
dia, migration, and epithelial-mesenchymal transition (EMT)
(33). The interaction of LMP2A with Itch may affect the forma-
tion and integrity of tight junctions and promote wound healing
migration. Itch has been shown to promote wound healing migra-
tion and the expression of features of EMT in the breast epithelial
cell line MCF10A (26). By regulating protein expression and sta-
bility through interaction with the ubiquitin ligase Itch, LMP2A
may target a group of proteins that can specifically promote
wound healing migration.
LMP2A activated two distinct signaling pathways to control
migration. Activation of both Syk and Akt required the ITAM
motif but were apparently activated independently as phosphor-
ylation of Akt and GSK3 was unaffected by the Syk inhibitor.
Both Syk and Akt however, converged to promote membrane
translocation of V-integrin and membrane localization and in-
tegrin activation promoted migration through activation of FAK
and recruitment of Src. These data suggest that Src family kinases
may contribute to migration through facilitating activation of Akt
and Syk through the ITAM motif and also through recruitment to
the FAK signaling complex initiated by integrin clustering. Differ-
ences in signaling were identified in Transwell migration assays
when migration of the two cell lines to FBS, collagen, and fi-
bronectin was compared. Migration to FBS, fibronectin, and col-
lagen all required the ITAM signaling domain of LMP2A and
downstream Syk tyrosine kinase activity. Migration to fibronectin
in HaCaT cells required a typical integrin-activated signaling
pathway, involving FAK, Src, and Akt. Migration of HFK to FBS
was impaired by inhibitors of FAK and Akt and by LiCl but was
unaffected by the Src inhibitor PP2, suggesting that the require-
ment for FAK signaling was independent of Src. FAK has been
shown to interact with other signaling mediators, including PI3K,
at Y397, the autophosphorylation site which binds Src (37).
LMP2A activation of FAK and Akt in HFK may also involve PI3K
and the adaptor protein Grb7, both of which have been shown to
interact with FAK in a Src-independent manner and promote mi-
gration.
Migration of HaCaT cells to collagen was distinct from migra-
tion to FBS and fibronectin, with the requirements for ITAM and
Syk being the only commonalities. LMP2A-induced migration to
FIG 8 LMP2A induces signaling pathways that promote membrane localization of V-integrin and epithelial migration. This schematic diagram summarizes
the data on mechanisms of LMP2A-induced migration. LMP2A induced two distinct signaling pathways from the ITAM domain by activating Syk and Akt. Syk
and Akt promoted translocation of V-integrin to membrane-enriched compartments of epithelial cells and subsequent activation of FAK and Src to control
migration. A separate signaling pathway initiated by Akt through inhibition of GSK3 may also relieve an inhibitory phosphorylation of FAK to promote
migration. TCN, triciribine; FAKI, FAK inhibitors; PP2, Src inhibitor.
Fotheringham et al.
10318 jvi.asm.org Journal of Virology
collagen was independent of FAK and all signaling pathways tar-
geted by LiCl and was slightly impaired by the Akt inhibitor
triciribine, but this effect was not statistically significant. Colla-
gen-mediated migration required Src activity, with PP2 com-
pletely blocking LMP2A-induced migration and partially block-
ing pBabe migration. Src has been shown previously to regulate
migration in a FAK-independent manner through nitric oxide
synthase and 91-integrin (12). FAK-independent, Src-depen-
dent signaling by LMP2A suggests an alternative role for Src in
controlling migration other than as part of the typical integrin/
FAK/Src signaling complex. The involvement of different signal-
ing pathways downstream of integrin activation when epithelial
cells were induced to migrate to FBS, fibronectin, or collagen sug-
gests that even with the common requirement of V-integrin,
downstream signaling is ligand dependent.
LMP2A has been previously shown to induce scratch assay
migration and Matrigel invasion by upregulating the laminin-
binding 6-integrin (21). Although 6-integrin was expressed in
HaCaT cells and HFK, and mRNA levels were induced by LMP2A
(data not shown), the limited ligand repertoire of 6-integrin im-
plied that other integrins must be involved to account for the
global effect LMP2A has on epithelial migration. HaCaT cells and
HFK expressed several integrins, including V, 2, 5, 1, and
6. Most integrin expression in whole-cell lysates was detected at
comparable levels and was not induced by LMP2A, although 5-
integrin and 6-integrin were slightly increased by LMP2A in
HaCaT cells. While LMP2A did not affect expression of most in-
tegrins at the protein or mRNA level (data not shown), the induc-
tion of V-integrin in the membrane-enriched fraction in a man-
ner dependent on the ITAM motif of LMP2A and Syk and Akt
activation suggests that LMP2A promotes migration by increasing
translocation of V-integrin to membrane-enriched compart-
ments of epithelial cells. Membrane translocation of V-integrin
was unaffected by PP2 and is therefore independent of Src, sug-
gesting that Src likely contributes to migration through integrin
and FAK signaling. The membrane translocation of V-integrin
may have broader effects due to its recognition of ligands contain-
ing the RGD active site, including fibronectin, vitronectin, fibrino-
gen, fibrillin, and thrombospondin. The ability of V-integrin to
recognize such a large number of ligands indicates that the effect
on V may be responsible for the ability of LMP2A to globally
control migration. A neutralizing antibody to V-integrin inhib-
ited migration to FBS, fibronectin, and collagen, supporting its
role in migration to several extracellular matrix ligands. LMP2A
has previously been shown to induce migration to both fibronec-
tin and collagen and migration to collagen required Syk activation
(16). Although not typically a collagen-binding integrin, V3-
integrin can bind denatured or proteolysed collagen (19, 34), and
LMP2A was recently reported to promote invasion of NPC cells by
upregulating the collagenase MMP-9 (15), suggesting the intrigu-
ing possibility that LMP2A can induce proteolysis of collagen
through MMPs to expose the RGD binding site. Although unde-
tectable in the membrane fractions by Western blotting, neutral-
izing antibody to 5-integrin also significantly inhibited LMP2A-
induced migration to fibronectin and collagen in HaCaT cells,
suggesting that 5 also contributes to migration. The contribution
of 5-integrin, which has a restricted repertoire of ligands, is likely
to be less important than the effects mediated by V-integrin. The
membrane translocation of V-integrin without effects on total
protein levels suggests that LMP2A controls integrin expression
posttranscriptionally. Posttranscriptional regulation of proteins
also contributes to LMP2A-mediated inhibition of epithelial dif-
ferentiation through stabilization of Np63 expression (8).
Nasopharyngeal carcinoma is a cancer that frequently metas-
tasizes and is consistently associated with expression of LMP2A.
Successful metastasis requires the tumor cell to resist cell death
and to interact with its local microenvironment, migrate, invade,
and induce angiogenesis at the secondary site (2). By regulating
integrin localization, LMP2A may promote metastasis by partici-
pating in migration, invasion, and interaction of the tumor cell
with the microenvironment. Although V-integrin was impor-
tant for all Transwell migration studied, cell type and ligand spec-
ificity may also depend on the  subunit required by each specific
ligand, and subunit expression can determine the activation of
downstream signaling pathways. 1-Integrin has been demon-
strated to interact with protein kinase C (PKC), whereas 3-
integrin interacts with Src (17). Phosphorylation and signaling
events activated by integrins also control their internalization, a
process that plays a key role in migration by redistributing integ-
rins during assembly and disassembly of adhesions at the leading
edge and the trailing edge of a migrating cell. -Integrin subunits
interact with adapter proteins like Dab-2, Numb, Rab-5, PKD1,
and ACAP1 that regulate internalization and recycling of integrins
(17). Since PKC is also inhibited by the GSK3 inhibitor LiCl, and
LiCl impaired LMP2A-induced migration to FBS and fibronectin,
PKC activity may be involved in signaling by the  subunit. -In-
tegrin subunit expression may also participate in specificity of
integrin signaling. Rab21 and p210RasGAP can interact with 1
and 2 subunits to mediate recycling (17). Further study of the
-integrin subunits expressed by epithelial cells and involved in
migration may clarify some of the differences in signaling path-
ways activated by different chemoattractants.
An important finding of this study is the dramatic effects of
LMP2A on the membrane translocation of the V-integrin and its
requirement for migration. Importantly, the broad specificity of
V for several extracellular ligands suggests that LMP2A would
therefore exert wide-ranging effects on cellular migration. The
effects on V-integrin membrane localization and epithelial mi-
gration required ITAM activation and activation of Syk, Akt, FAK,
and Src signaling pathways. Through its effects on integrin activity
and signaling, LMP2A expression likely contributes to cancer me-
tastasis by modulation of adhesion, migration, and invasion.
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